Furthermore, MYC plays an important role in suppressing the host anti-tumor immune response, through various mechanisms involving modifications to the tumor microenvironment via inhibitory cytokines (e.g., TGFβ and immunomodulatory molecules such as PD-L1, CD47, and MHC I)26–29. The gene discussed is CD274; the disease is neoplasm.